Alpha Lee, PostEra co-founder and CSO

NIH grants over $500M to cre­ate an­tivi­rals for fu­ture pan­demics

As the US tran­si­tions away from Covid-19 vac­cine sci­ence in­to more ther­a­peu­tic work, the NIH has award­ed $577 mil­lion to nine groups in an ef­fort to dri­ve an­tivi­ral de­vel­op­ment for Covid and a slew of oth­er virus­es.

The grants will cre­ate nine an­tivi­ral drug dis­cov­ery (AViDD) cen­ters, whose main goals are to do the pre­clin­i­cal dis­cov­ery work for Covid-19 drugs and oth­er virus­es “with high po­ten­tial to cause a pan­dem­ic in the fu­ture,” ac­cord­ing to the NIH press re­lease. The project will span five years, though the ini­tial grant mon­ey on­ly ex­tends out to the first three.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.